ID - 1273
IMMUNE MATURATION AND CHECKPOINT DYNAMICS DURING TYROSINE KINASE INHIBITOR DOSE REDUCTION PREDICT RELAPSE RISK IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA UNDERGOING TREATMENT DISCONTINUATION
LS Binellia, LC Palmab, CAB Garciaa, M Medeirosa, AG de Carvalhoa, BL Adjafrea, LO Marania, PS Scheucherb, JLS Schiavinatob, PMM Garibaldib, RL Paccab, FS Seguroc, RS Tavaresd, LL Almeidae, RS Welnerf, KBB Pagnanog, LL de Figueiredo-Pontesa
a Fundação Hemocentro de Ribeirão Preto (FUNDHERP), Faculdade de Medicina de Ribeirão Preto (FMRP), Universidade de São Paulo (USP), Ribeirão Preto, Brazil
b Hematology, Hemotherapy and Cell Therapy Division, Department of Medical Imaging, Hematology, and Clinical Oncology, Faculdade de Medicina de Ribeirão Preto (FMRP), Universidade de São Paulo (USP), Ribeirão Preto, Brazil
c Division of Hematology and Hemotherapy, Department of Clinical Medicine, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil
d Universidade Federal de Goiás (UFG), Goiânia, Brazil
e Hospital Amaral Carvalho (HAC), Jaú, Brazil
f Division of Hematology and Oncology, Department of Medicine, University of Alabama, Birmingham, United States
g Centro de Hematologia e Hemoterapia (Hemocentro), Universidade Estadual de Campinas (UNICAMP), Campinas, Brazil
